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Background: 
Cirrhosis patient need special attention, due to the lack of inappropriate medication 
could be fatal incidents and lead to death, so proper medication can improve the quality 
of life and help live longer. Gastrointestinal drugs include antacids, H2 blockers, proton 
pump inhibitors, anti-emetic, and 5-HT3 receptor antagonists. The drugs are often used 
to reduce the symptoms of gastrointestinal disorders in cirrhotic patients. 
Objective:  
To determine the profile of the use of gastrointestinal medications on the incidence of 
spontaneous bacterial peritonitis (SBP).  
Method: 
The design was retrospective, the data extracted from the medical records of patients 
during the month of January 2010-December 2010.  
Results: 
We analized SBP event in 48 patients (aged ≥ 23 years) who used gastrointestinal drugs 
at the hospital. The most widely gastrointestinal drug classes was proton pump inhibitor 
(PPI) (19 cases). Then, it was found 7 patients with SBP events after the treatment, 
involving PPI were 4 cases. SBP incident also occurred after administration of drug 
combinations 5HT3 receptor antagonist and H2-blockers (1 case) and combination of 
PPI and antiemetic (1 case), and combination PPI and antacids SBP (1 case). Outcomes 
related clinical of DRP events most often occur SBP is the emergence of new diseases. 
Coclusion: 
Further studies are needed on the relationship of gastrointestinal drugs used with 
incidence of SBP in cirrhosis patient. 
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